Clinical Trial Update: Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer. [EARLY_Phase 1]

View source ↗

Summary

A pilot Phase 1 study evaluating whether FDG-PET/CT can predict early chemotherapy response in ovarian cancer; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Fluorodeoxyglucose (FDG) (Fluorodeoxyglucose)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Ovarian Cancer | EARLY_Phase 1 | Status: COMPLETED